ANGELA PERSOHN: Open Payments
NPI 1619326402 · HUNTINGBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,761 in 110 payments from 24 companies in 2025. Trend: 2023 $1,148 · 2024 $1,374 · 2025 $1,761
Food & beverage: $1,761
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $247 |
| Novo Nordisk Inc | 14 | $226 |
| PFIZER INC. | 13 | $182 |
| Lilly USA, LLC | 10 | $166 |
| AstraZeneca Pharmaceuticals LP | 5 | $152 |
| GlaxoSmithKline, LLC. | 10 | $137 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $108 |
| Viatris Specialty LLC | 5 | $94 |
| Amgen Inc. | 6 | $92 |
| Exact Sciences Corporation | 3 | $49 |
Products named: VRAYLAR, Ozempic, MOUNJARO, CAPLYTA, NURTEC ODT, YUPELRI, BREZTRI, TRELEGY ELLIPTA.
Industry payments across IN — which companies pay providers there.
